SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-063983
Filing Date
2021-05-10
Accepted
2021-05-10 17:07:07
Documents
5
Effectiveness Date
2021-05-10

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2115500d1_s8.htm S-8 61942
2 EXHIBIT 5.1 tm2115500d1_ex5-1.htm EX-5.1 7829
3 EXHIBIT 23.1 tm2115500d1_ex23-1.htm EX-23.1 2995
4 GRAPHIC tm2115500d1_ex5-1img1.jpg GRAPHIC 12984
5 GRAPHIC tm2115500d1_ex5-1img2.jpg GRAPHIC 14796
  Complete submission text file 0001104659-21-063983.txt   112396
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-255972 | Film No.: 21908304
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences